Selective Ultrasound Screening for DDH 1991-2006
1 other identifier
observational
81,564
1 country
1
Brief Summary
Early treatment is considered essential for developmental dysplasia of the hip (DDH), but the choice of screening strategy is debated. The investigators evaluated the effect of a selective ultrasound (US) screening programme. All infants born in a defined region during 1991-2006 with increased risk of DDH, i.e. clinical hip instability, breech presentation, congenital foot deformities or a family history of DDH, were subjected to US screening at age one to three days. Severe sonographic dysplasia and/or dislocatable/dislocated hips were treated with abduction splints. Mild dysplasia and/or pathological instability, i.e. not dislocatable/dislocated hips were followed clinically and sonographically until spontaneous resolution, or until treatment became necessary. The minimum observation period was 5,5 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 1991
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1991
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 23, 2013
CompletedFirst Posted
Study publicly available on registry
May 31, 2013
CompletedMay 31, 2013
May 1, 2013
21.6 years
May 23, 2013
May 28, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
late dislocated or subluxated hips
late detected after 1 month of life, requiring treatment
first 5 years of life
Secondary Outcomes (4)
Number of participants who receive ultrasound follow-up for 6 weeks or more
first months of life
early treatment
first months of life
first surgical treatment
first five years of life
avascular necrosis of femoral head
first five years of life
Study Arms (1)
all newborns born 1991-2006
all newborns born 1991-2006
Eligibility Criteria
All infants born at the maternity unit at Haukeland University Hospital from January 1991 through December 2006 were included. The hospital provides the only delivery unit for the city and suburbs of Bergen and a large rural area within the Hordaland County. It serves a population of approximately 400 000 inhabitants, predominantly ethnic Norwegians. The annual birth rates varied from 4723 to 6010. Minimum observation time was 5,5 years.
You may qualify if:
- born at Haukeland University hospital January 1991-December 2006
You may not qualify if:
- Children with DDH due to neuromuscular syndromes were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bergenlead
- Helse Vestcollaborator
Study Sites (1)
Paediatric section, Radiology department, Haukeland University hospital, Bergen, Norway
Bergen, 5021, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Karen Rosendahl, PhD
Paediatric Section, Department of Radiology, Haukeland University hospital, Bergen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 23, 2013
First Posted
May 31, 2013
Study Start
January 1, 1991
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
May 31, 2013
Record last verified: 2013-05